
2022年第37届癌症免疫治疗学会年会(SITC)
江苏集萃药康生物科技股份有限公司将在2022年癌症免疫治疗学会--SITC大会上,介绍自主研发免疫缺陷小鼠模型--NCG二代小鼠模型


神经科学学会(Society for Neuroscience,SfN)会议海报
神经科学学会(Society for Neuroscience,SfN)会议海报


Humannized CD3E,D,G Mice an Ideal Model for Efficacy Study of CD3-bispecific Antibodies
Humannized CD3E,D,G Mice an Ideal Model for Efficacy Study of CD3-bispecific Antibodies


Preclinical evaluation of humanized PD1/GITR combination therapy using double humanized mouse
Preclinical evaluation of humanized PD1/GITR combination therapy using double humanized mouse


NCG-X: A novel animal model to evaluate preclinical studies
A novel animal model to evaluate preclinical studies of humanized erythroid reconstitution


CD137 humanized mice for preclinical efficacy evaluation of therapeutic antibodies
CD137 humanized mice for preclinical efficacy evaluation of therapeutic antibodies


A novel GEMM for preclinical evaluation of therapeutic antibodies against VISTA
BALB/c mice with humanized VISTA: A novel GEMM for preclinical evaluation of therapeutic antibodies against VISTA


Humanized mice for preclinical efficacy evaluation of drugs targeting CD73
Humanized mice for preclinical efficacy evaluation of drugs targeting CD73


huHSC-NCG mice for study of anti-human CD19 therapeutic antibodies
huHSC-NCG mice for study of anti-human CD19 therapeutic antibodies


Novel orthotopic pancreatic cancer cell lines derived from B6-KPC mice
Novel orthotopic pancreatic cancer cell lines derived from B6-KPC mice
